Emm
Smart menstrual cup with biosensors tracking flow and cycles in real time
Website: https://www.emm.co/
Cover Block
| Name | Emm |
| Tagline | Smart menstrual cup with biosensors tracking flow and cycles in real time |
| Headquarters | Bristol, UK |
| Founded | 2020 |
| Stage | Seed |
| Business Model | Direct-to-Consumer (DTC) |
| Industry | Healthtech |
| Technology | Hardware |
| Geography | Western Europe |
| Growth Profile | Venture Scale |
| Founding Team | Solo Founder |
| Funding Label | Seed (total disclosed ~$9,000,000) |
Links
- Website: https://www.emm.co
- LinkedIn: https://uk.linkedin.com/company/your-emm
The Short Version
Emm is building a hardware-first data platform for menstrual health, a category historically reliant on subjective user logs, with a $9 million seed round led by Lunar Ventures [TechCrunch, November 2025]. Founder Jenny Button conceived the idea in 2020, observing that consumer wearables offered no objective data on reproductive cycles, a gap she spent five years addressing through thousands of design iterations [SeedCue, November 2025]. The core product is a reusable, medical-grade silicone menstrual cup embedded with biosensors that measure flow volume and cycle metrics in real time, syncing data to a companion app [TechCrunch, November 2025]. The company operates a direct-to-consumer model and is in a pre-launch phase, targeting a UK rollout in early 2026 followed by a US entry in 2027 [SetSquared, November 2025].
Data Accuracy: GREEN -- Confirmed by multiple independent sources including TechCrunch, SeedCue, and SetSquared.
Taxonomy Snapshot
| Axis | Classification |
|---|---|
| Stage | Seed |
| Business Model | Direct-to-Consumer (DTC) |
| Industry / Vertical | Healthtech |
| Technology Type | Hardware |
| Geography | Western Europe |
| Growth Profile | Venture Scale |
| Founding Team | Solo Founder |
| Funding | Seed (total disclosed ~$9,000,000) |
The Company in Brief
Emm is a hardware-first company defined by a five-year development cycle. Jenny Button conceived Emm in 2020 while using consumer wearables that tracked general health but lacked objective menstrual cycle data [TechCrunch, November 2025]. This led to a prototyping process involving thousands of design iterations and extended user testing [SeedCue, November 2025].
Headquartered in Bristol, UK, the company's primary public milestone is an oversubscribed $9 million seed round in November 2025, led by Lunar Ventures [TechCrunch, November 2025]. A planned UK product launch was targeted for early 2026, with a U.S. entry slated for early 2027 [TechCrunch, November 2025]. As of May 2026, the company remains in a pre-launch phase.
Data Accuracy: GREEN -- Confirmed by Crunchbase, TechCrunch, and SeedCue.
What They Have Built
Emm's core device is a reusable menstrual cup made from medical-grade silicone, distinguished by integrated ultra-thin biosensors that measure flow volume, cycle length, frequency, and regularity in real time [TechCrunch, November 2025]. This positions it as an objective data capture tool. The cup is designed for up to 12 hours of use and recharges between cycles [Perplexity Sonar].
Data syncs via Bluetooth to a companion smartphone application. The app provides personalized health insights by establishing a user's baseline over an initial three-cycle period [SeedCue, November 2025]. The company emphasizes data privacy, with on-device processing mentioned as a feature [SetSquared, November 2025]. The team includes a Senior Electronics Engineer and a Clinical Research and Partnerships Manager [emm.co/products/emm-smart-cup, 2026].
Data Accuracy: YELLOW -- Core product claims are consistently reported, but detailed technical specifications and post-funding launch updates are not publicly available.
Market Size and Demand
| Metric | Value |
|---|---|
| Femtech Market 2022 | $51B |
| Femtech Market 2030 (projected) | $103B |
Demand drivers include increased consumer investment in health technology and a growing willingness to share personal health data. The primary substitute is the established market for disposable menstrual products, while adjacent markets include consumer health wearables like Oura and Whoop [TechCrunch, November 2025]. Any device interpreting health data for diagnostic purposes will face medical device regulatory scrutiny (e.g., FDA, CE marking) [SetSquared, November 2025].
Data Accuracy: YELLOW -- Market sizing is based on analogous third-party reports; specific segment data for smart menstrual hardware is not publicly confirmed.
Who Else Is Fighting for This
Emm enters a market defined by established consumer tracking habits and nascent clinical-grade hardware. The competitive map splits into three tiers: broad digital health apps (Clue, Flo), adjacent hardware substitutes (Oura), and physical product incumbents (Procter & Gamble, Essity).
Emm's defensible edge rests on its first-mover status in a specific hardware category and its investor-backed technical development. The five-year development cycle suggests non-trivial engineering hurdles in miniaturizing biosensors [SeedCue, November 2025]. Strategic capital includes Lunar Ventures (hardware expertise) and angels like Harpreet Rai (wearables) and Amar Shah (deep tech) [SetSquared, November 2025]. The partnership with Labcorp Venture Fund signals intent toward clinical validation.
Data Accuracy: YELLOW -- Competitive mapping is inferred from market context; no direct competitor names are confirmed in sources.
Opportunity
| Scenario | What happens | Catalyst | Why it's plausible |
|---|---|---|---|
| Clinical Research Partner | Emm devices become a standard tool in pharmaceutical and academic studies. | A published peer-reviewed study validating Emm's data. | Labcorp investment ties Emm to the clinical diagnostics ecosystem [SetSquared, November 2025]. |
| Consumer Health Subscription | The app evolves into a paid subscription service. | The launch of a premium tier. | Mirrors Oura's evolution from hardware to subscription [TechCrunch, November 2025]. |
| Enterprise Wellness Mandate | Emm is adopted as a covered benefit by employers. | A pilot program with a large employer. | Growing focus on femtech in corporate benefits. |
Data Accuracy: YELLOW -- Opportunity scenarios are extrapolated from cited investor strategy and product design.
Sources
- [TechCrunch, November 2025] Emm raises $9M seed to create one of the world's first smart menstrual cups | https://techcrunch.com/2025/11/18/emm-raises-9m-seed-to-create-to-launch-one-of-the-worlds-first-smart-menstrual-cups/
- [Crunchbase] Emm - Crunchbase Company Profile & Funding | https://www.crunchbase.com/organization/emm-126f
- [SeedCue, November 2025] Emm raises over $9 million to launch world's first smart menstrual solution | https://www.seedcue.com/post/emm-raises-over-9-million-to-launch-worlds-first-smart-menstrual-solution
- [SetSquared, November 2025] Emm raises over $9 million (£6.8m) to launch world's first smart menstrual solution | https://www.setsquared.co.uk/emm-raises-over-9-million-6-8m-to-launch-worlds-first-smart-menstrual-solution/
- [Perplexity Sonar] Research Brief
- [emm.co/products/emm-smart-cup, 2026] Product Team Page | https://www.emm.co/products/emm-smart-cup/
- [SLGuardian] Founder Profile
- [Grand View Research] Femtech Market Size Report
- [Bloomberg, April 2022] Oura Valuation Report
Articles about Emm
- Emm's Smart Cup Aims to Put a Biosensor in the Menstrual Cycle — The Bristol femtech startup, backed by $9 million and Oura's former CEO, is betting hardware can deliver the first objective data on menstrual flow.